PharmaEssentia Corporation (TPE:6446)
1,545.00
-15.00 (-0.96%)
Aug 28, 2026, 1:30 PM CST
PharmaEssentia Market Cap
PharmaEssentia has a market cap or net worth of 640.3 billion as of August 28, 2026. Its market cap has increased by 284.26% in one year.
Market Cap
640.30B
Enterprise Value
616.85B
Revenue
20.75B
Ranking
n/a
PE Ratio
83.52
Stock Price
1,545.00
ChartMarket Cap Chart
Since March 11, 2014, PharmaEssentia's market cap has increased from 39.38B to 640.30B, an increase of 1,525.78%. That is a compound annual growth rate of 25.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 640.30B | 268.35% |
| Dec 31, 2025 | 173.83B | -15.09% |
| Dec 31, 2024 | 204.73B | 78.68% |
| Dec 29, 2023 | 114.58B | -20.34% |
| Dec 30, 2022 | 143.84B | 84.26% |
| Dec 30, 2021 | 78.07B | 215.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 59.86B |
| Lotus Pharmaceutical | 51.65B |
| Center Laboratories | 25.43B |
| TTY Biopharm Company | 19.34B |
| Synmosa Biopharma | 16.14B |
| ScinoPharm Taiwan | 14.98B |
| YungShin Global Holding | 14.81B |
| Grape King Bio | 13.35B |